We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ZAL:XETRZalando SE Analysis

Data as of 2026-06-19 - not real-time

€24.25

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Zalando SE trades at €24.25, well below its DCF‑derived fair value of €156.6, implying a sizable upside potential. Revenue growth of 23.8% and a healthy free cash flow of €1.18 bn underscore strong top‑line momentum, yet the company still posts a modest profit margin of 0.9% and a negative operating margin, highlighting ongoing cost pressures. Technical analysis shows the price sitting above the 20‑day (23.78) and 50‑day (22.21) SMAs, but a bearish MACD histogram and decreasing volume suggest short‑term caution. The stock’s RSI of 59 and a neutral trend direction reinforce a balanced outlook, while the 30‑day volatility of 34% points to sizable price swings. Overall, the blend of attractive growth fundamentals, a stark valuation gap, and mixed near‑term technical signals positions Zalando as a compelling medium‑ to long‑term play, with a watchful eye on cost efficiency and market sentiment.
Given the absence of a dividend and a modest ROE of 4.3%, investors should focus on capital appreciation rather than income. The company’s debt‑to‑equity ratio of 52% is manageable, and its beta of 0.014 indicates low market correlation, though sector volatility remains high. In the context of the “Extreme Greed” market sentiment, the stock appears undervalued and poised for potential upside if operational improvements materialize.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near support at €20.96
  • Decreasing volume trend
  • Bearish MACD histogram

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Revenue growth of 23.8% YoY
  • Free cash flow exceeding €1 bn
  • Valuation upside of ~45% vs target price

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF fair value far above market price
  • Strong e‑commerce tailwinds in Europe
  • Improving operating efficiency potential

Key Metrics & Analysis

Financial Health

Revenue Growth23.80%
Profit Margin0.91%
P/E Ratio55.1
ROE4.28%
ROA2.44%
Debt/Equity52.18
P/B Ratio2.2
Op. Cash Flow€831.1M
Free Cash Flow€1.2B

Technical Analysis

TrendNeutral
RSI59.3
Support€20.96
Resistance€25.97
MA 20€23.78
MA 50€22.21
MA 200€23.34
MACDBearish
VolumeDecreasing
Fear & Greed Index91.46

Valuation

Fair Value€156.61
Target Price€35.13
Upside/Downside44.87%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta0.01
Volatility34.26%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.